You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 歌禮制藥-B盤中漲5% 獲納入MSCI中國小型股指數
格隆匯 05-17 13:54
格隆匯5月17日丨歌禮制藥-B(1672.HK)盤中漲5.21%,報4.04港元,總市值44億港元。歌禮制藥-B16日宣佈其獲納入MSCI中國小型股指數,將於2022年5月31日收市後生效。歌禮創始人、董事會主席兼首席執行官吳勁梓博士表示,歌禮獲納入MSCI中國小型股指數反映了資本市場對公司業務和發展前景的認可和信心,這有助於吸引更多投資者,提升股票流通性。公司將繼續發揮強勁的研發能力,聚焦六大候選藥物,加速全球臨牀開發,包括用於治療新冠肺炎的口服藥ASC10和ASC11,致力於實現乙肝功能性治癒的ASC22,用於治療複發性膠質母細胞瘤的ASC40,用於治療原發性膽汁性膽管炎的ASC42,以及用於治療痤瘡的ASC40。未來兩年,這六款候選藥物有望遞交新藥上市申請和/或獲批上市。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account